You are here: Home » Companies » News
Business Standard

Big pharma cos behind campaign against tobacco: ITGA

Says campaign by pharma cos to increase nicotine patch sales

Press Trust of India  |  Hyderabad 

International Tobacco Growers Association (ITGA), which opposes some of the articles of World Health Organisation's (WHO) Framework Convention on Tobacco Control (FCTC), today alleged big pharmaceutical are behind the campaign.

It said this was to reduce cigarette production and thereby increase nicotine patch sales, which is used to help people quit smoking.

The FCTC has been adopted by 176 countries, including India since its inception in 2005. The measures are aimed at promoting alternatives to tobacco growing, production, besides reducing the acreage of plantation.

India is also one of the countries that have adopted the FCTC.

ITGA chief executive Antonio Abrunhosa said some of the NGOs with offices in hundreds of countries are also behind the WHO move which will threaten millions of farmers depending on tobacco farming.

"This is big war. Pharmaceutical always dream of replacing each cigarette with nicotine patch. They have been campaigning very heavily against tobacco for many years. They fund heavily for the campaign against tobacco," Abrunhosa alleged while talking to reporters.

"We are poor farmers, we cannot fight with big They have millions of dollars. But we have millions of people on our side," he added.

The fifth session of the Conference of the Parties to the WHO FCTC (COP5) will be held from November 12-17 in Seoul, he said.

Abrunhosa said studies have shown that it is difficult to replace tobacco with other crops with the same level of income and employment.

He said the proposal if adopted would threaten the source of livelihood of millions of tobacco farmers and their dependent relatives globally.

India is the third largest tobacco producer in the world and thousands of farmers, farm workers and farm families depend on income derived from tobacco farming.

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Tue, November 06 2012. 16:39 IST